Strides Arcolab rose 0.17% to Rs 151 at 16:03 IST on BSE after the company said it has received approval from US Food and Drug Administration for its penicillin sterile facility in Bangalore.
The company made this announcement during trading hours today,
Meanwhile, BSE Sensex was down 49.38 points or 0.31% to 16,073.77.
On BSE, 35,488 shares were traded in the counter. The scrip had an average daily volume of 24,593 shares in the past one quarter.
The stock hit a high of Rs 159.95 and a low of Rs 147.30 so far during the day. The stock had a 52-week high of Rs 372 on
The company’s current equity is Rs 35 crore. Face value per share is Rs 10.
The penicillin sterile facility in
Strides Arcolab reported net loss of Rs 133.40 crore in Q4 December 2007 as compared to net profit of Rs 12.97 crore in Q4 December 2006. Net sales fell 41.4% to Rs 75.76 crore in Q4 December 2007 over Q4 December 2006.
The company manufactures ethical pharmaceutical products, over the counter (OTC) products and nutraceuticals. It performs its activities through two segments, pharma and contract research and manufacturing (CRAM).
No comments:
Post a Comment